Revvity, Inc. (RVTY) Launches its New In Vivo Imaging Center of Excellence

Revvity, Inc. (NYSE:RVTY) is included in our list of the 14 Tech Stocks to Sell Now According to Ken Fisher.

Revvity, Inc. (NYSE:RVTY) launched its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina’s Research Triangle, on September 2, 2025. With this launch, the company consolidates its expertise to accelerate next-generation imaging innovation.

With this achievement, Revvity, Inc. (NYSE:RVTY) expects to advance instruments and AI-driven software that enhance disease research workflows by bringing together teams specializing in machine learning, optics, micro-CT, ultrasound, and applied biology.

Revvity, Inc. (NYSE:RVTY) unveiled its IVIS optical systems, Quantum GC3 microCT, Vega preclinical ultrasound, and VivoJect targeted delivery system technologies at the site. By bringing multidisciplinary teams within one site, the company plans to transform imaging modalities, helping researchers investigate cancer progression, tissue morphology, and therapeutic efficacy.

Revvity, Inc. (NYSE:RVTY) offers advanced health science solutions across multi-omics, imaging, biomarkers, and informatics segments. It is one of the stocks to sell.

While we acknowledge the potential of RVTY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Unstoppable Canadian Stocks to Buy Now and 14 Best IT Stocks to Buy for the Long Term.

Disclosure: None.